Labs looking for biomarkers could really help us. We could not only treat disease but help with best targeted preventative health tips for everyone. It has the potential to give people more years with better quality of life. LessBarriers.com #PrevenativeHealth #Neurology #PersonalizedHealthcare #Biomarkers
Most viewed in the last 7 days from JAMA Neurology: This Viewpoint discusses using digital biomarkers for neurodegenerative disease. https://ja.ma/40n4q8d
Most viewed in the last 7 days from JAMA Neurology: This Viewpoint discusses using digital biomarkers for neurodegenerative disease. https://ja.ma/3DYb25L
Most viewed in the last 7 days from JAMA Neurology: This Viewpoint discusses using digital biomarkers for neurodegenerative disease. https://ja.ma/40n4q8d
Sano CEO Patrick Short and Dr. Andrea Gropman, an expert in pediatric neurology, genetics, and inborn errors of metabolism, recently sat down for a fascinating conversation on the impact of genetics on modern medical practice. In the clip below, Dr. Gropman discusses industry areas she's keen to see improve. Feel free to check out the full webinar here: https://lnkd.in/emNSfvfY. #PrecisionMedicine #Genomics #ClinicalTrials
Proposal & Business Strategy | Healthcare & Pharma |Process Excellence | IIM Indore'26 | E.P.H.M | Proposal Associate at LabCorp.
In a recent conversation with Robert Martone, scientific discipline director for neurology, we discussed the acceleration and expansion of biomarkers in therapeutic development for neurodegenerative diseases such as Alzheimer’s, Parkinson’s, dementia and more. Read the full Q&A: https://lnkd.in/gc_S7eiv
Vice President and Enterprise Head of Cell and Gene Therapy at Labcorp Drug Development
In a recent conversation with Robert Martone, scientific discipline director for neurology, we discussed the acceleration and expansion of biomarkers in therapeutic development for neurodegenerative diseases such as Alzheimer’s, Parkinson’s, dementia and more. Read the full Q&A: https://lnkd.in/eteEwcaG
Drug Development/Early Development | Safety Assessment/Toxicology/DMPK/Bioanalytical/IND Enabling | Business Development
In a recent conversation with Robert Martone, scientific discipline director for neurology, we discussed the acceleration and expansion of biomarkers in therapeutic development for neurodegenerative diseases such as Alzheimer’s, Parkinson’s, dementia and more. Read the full Q&A: https://lnkd.in/gRSXXdku
Strategic Marketing | Customer-Focused | Global Solutions | Precision Medicine | Cell & Gene Therapy | Oncology
In a recent conversation with Robert Martone, scientific discipline director for neurology, we discussed the acceleration and expansion of biomarkers in therapeutic development for neurodegenerative diseases such as Alzheimer’s, Parkinson’s, dementia and more. Read the full Q&A: https://lnkd.in/g5WfaQeQ
In a recent conversation with Robert Martone, scientific discipline director for neurology, we discussed the acceleration and expansion of biomarkers in therapeutic development for neurodegenerative diseases such as Alzheimer’s, Parkinson’s, dementia and more. Read the full Q&A: https://lnkd.in/gnhdGAiZ
In a recent conversation with Robert Martone, scientific discipline director for neurology, we discussed the acceleration and expansion of biomarkers in therapeutic development for neurodegenerative diseases such as Alzheimer’s, Parkinson’s, dementia and more. Read the full Q&A: https://lnkd.in/gtdcTN2e
In a recent conversation with Robert Martone, scientific discipline director for neurology, we discussed the acceleration and expansion of biomarkers in therapeutic development for neurodegenerative diseases such as Alzheimer’s, Parkinson’s, dementia and more. Read the full Q&A: https://lnkd.in/gThJ-4Y3
